This excerpt taken from the WBMD 10-Q filed Aug 9, 2006.
(b) Use of Proceeds
On September 28, 2005, we sold 7,935,000 shares of our Class A Common Stock at a price of $17.50 per share in our initial public offering or IPO. The shares of Class A Common Stock sold in the IPO were registered under the Securities Act of 1933, as amended, on a Registration Statement on Form S-1 (No. 333-124832). Our net proceeds from the offering were $125,392 after deducting underwriting discounts and commissions and our offering expenses. Through June 30, 2006, the proceeds from the IPO and the $40,000 cash capital contribution from Emdeon in September 2005 have been invested in U.S. Treasury Notes and auction rate securities, and used to fund the Conceptis, eMedicine and Summex acquisitions, the combined earn out payments to RxList and MedicineNet of $9,637, capital expenditures and working capital requirements.